Answers are grounded in this paper and cite their sources.
Organisation requires member countries to grant and enforce patents for new pharmaceutical products (Maskus, 2000a; and Gorlin, 1999).More precisely, developers of new drugs have enjoyed exclusive marketing rights (EMRs) in all WTO members since 1
No takes yet. Share an insight, caveat, or question.
Ganslandt et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: